معرفی
Aktar Ali is an Associate Research Professor and Director of the Biological Screening Core at the Warren Family Center for Drug Discovery, University of Notre Dame. He has held significant academic and research roles at institutions including the University of Texas Southwestern Medical Center, University of Nebraska, and NYU School of Medicine.
Education:
- Ph.D. in Pharmaceutical Science, Niigata University of Pharmacy and Applied Life Science, Japan (1999)
- M.Sc. in Inorganic Chemistry, University of Chittagong, Bangladesh (1994)
- B.Sc. in Chemistry, University of Chittagong, Bangladesh (1991)
Dr. Ali's research focuses on biochemistry, metabolic disorders, and drug discovery, with particular emphasis on vitamin D metabolism, mineral homeostasis, and cancer biology. His work bridges molecular mechanisms with translational applications in medicine. He has made significant contributions to understanding gene polymorphisms related to vitamin D deficiency and colorectal cancer susceptibility, as well as metabolic regulation in obesity and aging.
His recent publications (2023–2025) reflect a strong trend in genetic and molecular mechanisms of disease, particularly in endocrine and oncological contexts. These works integrate biochemical analysis with clinical implications, often using advanced models such as age-mimetic systems and metabolic phenotyping. The research spans disciplines including biochemistry, genetics, pharmacology, and molecular oncology.
While no scientific awards are mentioned in the provided text, his leadership roles in core research facilities highlight his technical and managerial expertise in high-impact biomedical research.
Dr. Ali has advised or collaborated with numerous researchers, though formal advisees are not listed. His career includes grant-supported research, particularly through institutional core facilities and collaborative projects in drug discovery and metabolic phenotyping. He has served as Core Director in multiple institutions, indicating sustained involvement in funded research infrastructure.
He leads the Biological Screening Core at the Warren Family Center for Drug Discovery, a key facility supporting high-throughput screening and translational research at the University of Notre Dame. This lab plays a critical role in advancing drug discovery pipelines, particularly in targeting metabolic and oncological pathways.
